INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹604 Cr | ₹422 Cr | ₹205 Cr | ₹157 Cr | ₹158 Cr |
What is the latest Total Non-Current Liabilities ratio of INDOCO REMEDIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹604 Cr |
| Mar2024 | ₹422 Cr |
| Mar2023 | ₹205 Cr |
| Mar2022 | ₹157 Cr |
| Mar2021 | ₹158 Cr |
How is Total Non-Current Liabilities of INDOCO REMEDIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹604 Cr | 43.05 | |
| Mar2024 | ₹422 Cr | 105.37 | |
| Mar2023 | ₹205 Cr | 31.19 | |
| Mar2022 | ₹157 Cr | -1.12 | |
| Mar2021 | ₹158 Cr | - | |
Compare Total Non-Current Liabilities of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,162.1 Cr | -1.9% | 19.2% | -15.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,299.0 Cr | 1.4% | 1.2% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,207.0 Cr | -0.5% | -0.6% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,721.0 Cr | 2.1% | 1.5% | 42.2% | Stock Analytics | |
| CIPLA | ₹117,420.0 Cr | 6.4% | 1.6% | -3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,876.0 Cr | 6.2% | 1.6% | 0.2% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -1.9% |
19.2% |
-15.2% |
| SENSEX | -0.4% |
0.8% |
-5.3% |
You may also like the below Video Courses